Home » Stocks » OLMA

Olema Pharmaceuticals, Inc. (OLMA)

Stock Price: $51.00 USD 1.20 (2.41%)
Updated November 30, 4:00 PM EST - Market closed
After-hours: $53.00 +2.00 (3.92%) Nov 30, 5:18 PM

OLMA Stock Price Chart

Key Info

Market Cap 1.91B
Revenue (ttm) n/a
Net Income (ttm) -14.88M
Shares Out 38.52M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 30
Last Price $51.00
Previous Close $49.80
Change ($) 1.20
Change (%) 2.41%
Day's Open 50.25
Day's Range 49.21 - 52.01
Day's Volume 114,605
52-Week Range 47.11 - 52.78

OLMA Stock News

GlobeNewsWire - 1 week ago

SAN FRANCISCO, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”), a clinical-stage biopharmaceutical company focused on the discovery, development and...

GlobeNewsWire - 1 week ago

SAN FRANCISCO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”), a clinical-stage biopharmaceutical company focused on the discovery, development and...

About OLMA

Olema Pharmaceuticals, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead program is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of metastatic or locally advanced, ER-positive, and human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Industry
Biotechnology
IPO Date
Nov 19, 2020
CEO
Sean Bohen
Employees
0
Stock Exchange
NASDAQ
Ticker Symbol
OLMA

Financial Performance

Financial Statements